RCT in 208 children aged 5–9 with premyopia or low myopia: atropine 0.01% did not significantly slow 2-year myopia progression vs placebo (premyopia -0.82D vs -0.96D, p=0.328). Incident myopia was 44.8% vs 42.6% (p=0.896).
RCTn = 208
Chia et al. Effect of low-dose atropine on young premyopic and low-myopic children: atropine treatment of myopia (ATOM3) - a randomised control trial